| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,833,400 | 1,682,800 | 1,696,500 | 2,041,000 | | Cost of Revenue | 445,100 | 427,100 | 446,400 | 508,000 | | | Gross Profit | 1,388,300 | 1,255,700 | 1,250,100 | 1,533,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,149,700 | 1,151,700 | 1,159,000 | 1,262,400 | | Non Recurring | 18,200 | 118,700 | 20,800 | 300 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 220,400 | (14,700) | 70,300 | 270,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 200,800 | (14,700) | 70,300 | 270,300 | | Interest Expense |
-
| 20,200 | 20,600 | 19,600 | | Income Before Tax | 200,800 | (34,900) | 49,700 | 250,700 | | Income Tax Expense | 63,000 | (22,500) | 21,400 | 89,400 | | Minority Interest | 2,900 | (5,500) | (1,100) | (3,300) | | | | Net Income From Continuing Ops | 140,700 | (17,900) | 27,200 | 158,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 140,700 | (17,900) | 27,200 | 158,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $140,700 | ($17,900) | $27,200 | $158,000 |
|
0.01% Nasdaq 
0.22%
Income Statement
